Fny Investment Advisers, LLC Aldeyra Therapeutics, Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$6.31 - $8.13 $631 - $813	-100 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$4.41 - $6.12 $441 - $612	100 New	100 $0
Q4 2018 Jan 22, 2019	SELL	$7.26 - $13.29 $220,740 - $404,082	-30,405 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$6.8 - $14.35 $138,754 - $292,811	20,405 Added 204.05%	30,405 $418,000
Q2 2018 Jul 18, 2018	BUY	$6.95 - $9.18 $69,500 - $91,800	10,000 New	10,000 $79,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $290M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.